LANSOZ 30 CAPSULES
Lansoprazole 30 mg.
Lansoz contains Lansoprazole which is a proton-pump inhibitor (PPI) which prevents the stomach from producing gastric acid. It is indicated in Peptic Ulcers, Gastric ulcers, Duodenal ulcers, NSAID-induced ulcers, Zollinger-Ellison Syndrome, Gastroesophageal reflux disease and in supportive treatment of Helicobacter pylori infection, alongside antibiotics.
Omeprazole Formulations
OMCURE CAPSULES
Omeprazole 20 mg.
Omcure contains Omeprazole which is a proton pump inhibitor. It acts by inhibiting H+/K+ ATPase enzyme system and thus blocks final step of acid production irrespective of the stimulus. It is superior choice over antacid. It is indicated in Peptic Ulcers, Gastric ulcers, Duodenal ulcers, NSAID-induced ulcers, Zollinger-Ellison Syndrome and Gastroesophageal reflux disease.
OMCURE 40 CAPSULES
Omeprazole 40 mg.
Omcure contains Omeprazole which is a proton pump inhibitor. It acts by inhibiting H+/K+ ATPase enzyme system and thus blocks final step of acid production. It is indicated in Peptic Ulcers, Gastric ulcers, Duodenal ulcers, NSAID-induced ulcers, Zollinger-Ellison Syndrome and Gastroesophageal reflux disease.
OMCURE SR CAPSULES
Omeprazole 20 mg. &Domperidone 30 mg.
Omcure SR contains Omeprazole which is a proton pump inhibitor, acts by inhibiting H+/K+ ATPase enzyme system and thus blocks final step of acid production and Domperidone which increases gastric motility. It is sustained release formulation. Combination is indicated in Nausea, Vomiting, Peptic Ulcers, Gastric ulcers, Duodenal ulcers, NSAID-induced ulcers, Zollinger-Ellison Syndrome and Gastroesophageal reflux disease.
OMCURE D CAPSULES
Omeprazole 20 mg. &Domperidone 10 mg.
Omcure SR contains Omeprazole which is a proton pump inhibitor, acts by inhibiting H+/K+ ATPase enzyme system and thus blocks final step of acid production and Domperidone which is an anti-dopaminergic drug, thus increases gastric motility. Combination is indicated in Nausea, Vomiting, Peptic Ulcers, Gastric ulcers, Duodenal ulcers, NSAID-induced ulcers, Zollinger-Ellison Syndrome and Gastroesophageal reflux disease.
Pantoprazole Formulations
PEPCARE 40 INJECTION
Pantoprazole 40 mg
Pepcare contains Pantoprazole. It is a proton-pump inhibitor (PPI) which prevents the stomach from producing gastric acid. The inhibition is dose dependent and affects both basal and stimulated acid secretion. It is indicated in H2 blocker resistant gastric ulcers, Peptic Ulcers, Duodenal ulcers, NSAID-induced ulcers, Zollinger-Ellison Syndrome and Gastroesophageal reflux disease.and in supportive treatment of Helicobacter pylori infection, alongside antibiotics.
PEPCARE 40 TABLETS
Pantoprazole 40 mg
Pepcare contains Pantoprazole. It is a proton-pump inhibitor (PPI) which prevents the stomach from producing gastric acid. The inhibition is dose dependent and affects both basal and stimulated acid secretion. It is indicated in H2 blocker resistant Gastric ulcers, Duodenal ulcers, Peptic Ulcers, NSAID-induced ulcers, Zollinger-Ellison Syndrome, gastroesophageal reflux disease and in supportive treatment of Helicobacter pylori infection, alongside antibiotics.
PEPCARE FR TABLETS
Pantoprazole 40 mg. With sodium Bicarbonate as buffer (Fast Release) Tab.
Pepcare FR is fast release formulation containing Pantoprazole with Sodium Bicarbonate as buffer which increases the pH. It is a proton-pump inhibitor (PPI) which prevents the stomach from producing gastric acid. The inhibition is dose dependent and affects both basal and stimulated acid secretion. It is indicated in H2 blocker resistant Gastric ulcers, Peptic Ulcers, Duodenal ulcers, NSAID-induced ulcers, Zollinger-Ellison Syndrome, Gastroesophageal reflux disease and in supportive treatment of Helicobacter pylori infection, alongside antibiotics.
PEPCARE D TABLETS
Pantoprazole 40 mg. & Domperidone 10 mg.
Pepcare D contains Pentoprazole and Domperidone. Pentoprazole is a proton pump inhibitor, acts by inhibiting H+/K+ ATPase enzyme system and thus blocks final step of acid production and Domperidone which is an anti-dopaminergic drug. It is indicated in H2 blocker resistant gastric ulcers, Peptic Ulcers, duodenal ulcers, NSAID-induced ulcers, Zollinger-Ellison Syndrome, gastroesophageal reflux disease and in supportive treatment of Helicobacter pylori infection, alongside antibiotics.
Pepcare SR contains Pentoprazole which is proton pump inhibitor and Domperidone which is an anti-dopaminergic drug. It is sustained release formulation giving prolonged effect over the period of time. It is indicated in gastric ulcers, Peptic Ulcers , duodenal ulcers, NSAID-induced ulcers, gastroesophageal reflux disease, Zollinger-Ellison Syndrome, reflux oesophagitis and in adjunctive treatment of Helicobacter pylori infection, alongside antibiotics.
Rabifine contains Rabeprazole. It is a proton-pump inhibitor (PPI) which prevents the stomach from producing gastric acid. The inhibition is dose dependent and affects both basal and stimulated acid secretion. It is indicated in Gastritis, Duodenitis, Peptic acid disease, NSAID-induced ulcers, Gastroesophageal reflux disease, Supportive treatment of Helicobacter pylori infection, alongside antibiotics and in treatment of healed GORD (erosive or ulcerative).
Rabifine D contains Rabeprazole which is proton pump inhibitor and Domperidone which is an anti-dopaminergic drug. It is indicated in Gastritis, Duodenitis, Peptic acid disease, NSAID-induced ulcers, Gastroesophageal reflux disease, Supportive treatment of Helicobacter pylori infection, alongside antibiotics and in treatment of healed GORD (erosive or ulcerative).
RABIFINE FR TABLETS
Rabeprazole sodium 20 mg. With sodium Bicarbonate as buffer (Fast Release) Tab.
Rabifine FR contains Rabeprazole which is proton pump inhibitor. It is the fast release formulation with Sodium Bicarbonate as buffer which increases the pH. It provides consistent 24- hrs acid control. It is indicated in Gastritis, Duodenitis, Peptic acid disease, NSAID-induced ulcers, Gastroesophageal reflux disease, Supportive treatment of Helicobacter pylori infection, alongside antibiotics and in treatment of healed GORD (erosive or ulcerative).
RABIFINE PLUS CAPSULE
Rabeprazole sodium 20 mg. & Itopride Hydrochloride SR 150 mg. Cap.
Rabifine Plus contains Rabeprazole and Itopride. Rabeprazole is a proton-pump inhibitor (PPI) which prevents the stomach from producing gastric acid and Itopride which is a prokinetic drugs inhibiting dopamine and have a gastrokinetic effect. It is indicated in Gastritis, Duodenitis, Peptic acid disease, NSAID-induced ulcers, Gastroesophageal reflux disease, Supportive treatment of Helicobacter pylori infection, alongside antibiotics and in treatment of healed GORD (erosive or ulcerative).
RABIFINE INJECTION
Rabeprazole sodium 20 mg
Rabifine contains Rabeprazole. It is a proton-pump inhibitor (PPI) which prevents the stomach from producing gastric acid. The inhibition is dose dependent and affects both basal and stimulated acid secretion. It is indicated in Gastritis, Duodenitis, Peptic acid disease, NSAID-induced ulcers, Gastroesophageal reflux disease, Supportive treatment of Helicobacter pylori infection, alongside antibiotics and in treatment of healed GORD (erosive or ulcerative).
Rabifine SR contains Rabeprazole which is proton pump inhibitor and Domperidone which is an anti-dopaminergic drug. It is indicated in Gastritis, Duodenitis, Peptic acid disease, NSAID-induced ulcers, Gastroesophageal reflux disease, Supportive treatment of Helicobacter pylori infection, alongside antibiotics and in treatment of healed GORD (erosive or ulcerative).
Rabifine XT contains Rabeprazole which is proton pump inhibitor and Zinc carnosine which has gastrointestinal protective activity. It is indicated in Gastritis, Duodenitis, Peptic acid disease, NSAID-induced ulcers, Gastroesophageal reflux disease, Supportive treatment of Helicobacter pylori infection, alongside antibiotics and in treatment of healed GORD (erosive or ulcerative).
Esomcure contains Esomeprazole. It is a proton-pump inhibitor (PPI) which prevents the stomach from producing gastric acid. The inhibition is dose dependent and affects both basal and stimulated acid secretion. It is indicated in Gastritis, Duodenitis, Peptic acid disease, NSAID-induced ulcers, Gastroesophageal reflux disease, Supportive treatment of Helicobacter pylori infection, alongside antibiotics and in treatment of healed GORD (erosive or ulcerative).
Esomcure contains Esomeprazole. It is a proton-pump inhibitor (PPI) which prevents the stomach from producing gastric acid. The inhibition is dose dependent and affects both basal and stimulated acid secretion. It is indicated in Gastritis, Duodenitis, Peptic acid disease, NSAID-induced ulcers, Gastroesophageal reflux disease, Supportive treatment of Helicobacter pylori infection, alongside antibiotics and in treatment of healed GORD (erosive or ulcerative).
Sucralfate Formulations
SUKAL SUSPENSION
Sucralfate 1 gm. / 10 ml. Susp.
Sukal contains Sucralfate which is aluminium salt of Sulfated Sucrose. It forms complex with proteineous exudates in the ulcer and adheres to damaged ulcer as gel lining and protects against acids and enzymes so that healing can occur. It is indicated in Duodenal ulcers, Gastric ulcers, Chronic Gastritis and Bile reflux.
SUKAL O SUSPENSION
Sucralfate 1 gm. & Oxethazaine 20 mg. per 10 ml. Susp.
Sukal O contains combination of Sucralfate which is a sucrose sulfate-aluminium complex and oxethazine which is a topical anesthetic, reduces gastric irritation and burning. Combination works by binding to the Hydrochloric Acid in the stomach and act like acid buffer. It is indicated in Duodenal ulcers, Gastric ulcers, Chronic gastritis and Bile reflux.
